← Back to Screener
Abbott Laboratories (ABT)
Price$95.47
Favorite Metrics
Price vs S&P 500 (26W)-32.93%
Price vs S&P 500 (4W)-17.28%
Market Capitalization$165.20B
P/E Ratio (Annual)25.32x
Indicated Dividend Yield (Annual)2.64%
All Metrics
P/CF (Annual)17.27x
Book Value / Share (Quarterly)$30.02
P/TBV (Annual)4.67x
Indicated Dividend (Annual)$2.36
Revenue Growth (3Y)0.51%
Cash Flow / Share (Quarterly)$4.26
Payout Ratio (TTM)63.09%
Price vs S&P 500 (YTD)-26.70%
Gross Margin (TTM)56.50%
Net Profit Margin (TTM)13.91%
EPS (TTM)$3.59
10-Day Avg Trading Volume11.68M
EPS Excl Extra (TTM)$3.59
Revenue Growth (5Y)5.08%
EPS (Annual)$3.73
Dividend / Share (Annual)$2.37
ROI (Annual)10.03%
Gross Margin (Annual)56.66%
Net Profit Margin (5Y Avg)18.65%
Cash / Share (Quarterly)$5.15
P/E Basic Excl Extra (TTM)26.32x
Revenue Growth QoQ (YoY)7.78%
EPS Growth (5Y)8.20%
P/E Normalized (Annual)25.32x
ROA (Last FY)7.52%
Revenue Growth TTM (YoY)6.59%
EBITD / Share (TTM)$5.70
ROE (5Y Avg)18.82%
Operating Margin (TTM)17.09%
Cash Flow / Share (Annual)$4.26
P/B Ratio3.17x
P/B Ratio (Quarterly)4.18x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)3.83x
Net Interest Coverage (TTM)63.71x
ROA (TTM)7.76%
EPS Growth QoQ (YoY)-18.70%
EV / EBITDA (TTM)16.49x
EPS Incl Extra (Annual)$3.73
Current Ratio (Annual)1.58x
Quick Ratio (Quarterly)1.02x
3-Month Avg Trading Volume10.29M
52-Week Price Return-24.36%
EV / Free Cash Flow (Annual)22.94x
P/E Incl Extra (TTM)26.32x
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$26.84
P/S Ratio (Annual)3.73x
Asset Turnover (Annual)0.51x
52-Week High$139.06
Operating Margin (5Y Avg)17.73%
EPS Excl Extra (Annual)$3.73
CapEx CAGR (5Y)-0.06%
Tangible BV CAGR (5Y)20.96%
26-Week Price Return-28.39%
Quick Ratio (Annual)1.02x
13-Week Price Return-23.19%
Total Debt / Equity (Annual)0.25x
Current Ratio (Quarterly)1.58x
Enterprise Value$169,611.9
Revenue / Share Growth (5Y)5.53%
Asset Turnover (TTM)0.53x
Book Value / Share Growth (5Y)10.15%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)3.03x
Pretax Margin (Annual)19.10%
Cash / Share (Annual)$5.15
3-Month Return Std Dev29.64%
Gross Margin (5Y Avg)56.18%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)6.26%
EBITDA Interim CAGR (5Y)-6.39%
ROE (Last FY)12.51%
Net Interest Coverage (Annual)55.98x
EPS Basic Excl Extra (Annual)$3.73
P/FCF (TTM)22.34x
Receivables Turnover (TTM)5.97x
EV / Free Cash Flow (TTM)22.94x
Total Debt / Equity (Quarterly)0.25x
EPS Incl Extra (TTM)$3.59
Receivables Turnover (Annual)5.97x
ROI (TTM)10.23%
Dividend Growth Rate (5Y)10.37%
P/S Ratio (TTM)3.66x
Pretax Margin (5Y Avg)18.10%
Revenue / Share (Annual)$25.36
Tangible BV / Share (Annual)$26.84
Forward P/E17.17x
Free OCF CAGR (5Y)5.26%
Price vs S&P 500 (52W)-54.88%
P/E Ratio (TTM)26.32x
EPS Growth TTM (YoY)-53.59%
Year-to-Date Return-23.80%
5-Day Price Return-4.82%
EPS Normalized (Annual)$3.73
ROA (5Y Avg)10.10%
Net Profit Margin (Annual)14.72%
Month-to-Date Return-7.01%
Cash Flow / Share (TTM)$4.80
EBITD / Share (Annual)$5.88
EPS Growth (3Y)-1.71%
Operating Margin (Annual)18.17%
LT Debt / Equity (Annual)0.19x
P/CF (TTM)17.27x
ROI (5Y Avg)13.71%
P/E Excl Extra (TTM)26.32x
LT Debt / Equity (Quarterly)0.19x
EPS Basic Excl Extra (TTM)$3.59
P/TBV (Quarterly)4.67x
Payout Ratio (Annual)63.09%
P/B Ratio (Annual)4.18x
Dividend / Share (TTM)$2.37
Inventory Turnover (TTM)3.03x
Pretax Margin (TTM)18.03%
Book Value / Share (Annual)$30.02
Price vs S&P 500 (13W)-24.33%
Net Margin Growth (5Y)2.53%
Dividend Yield (TTM)2.49%
Beta0.72x
P/FCF (Annual)22.34x
Revenue / Share (TTM)$25.84
ROE (TTM)12.89%
52-Week Low$93.92
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
3.97
4.00
4.00
4.03
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
ABTAbbott Laboratories | 3.66x | 6.59% | 56.50% | 8.20% | $95.47 |
LLYEli Lilly & Co. | 13.08x | 44.70% | 83.04% | 27.59% | $903.99 |
JNJJohnson & Johnson | 5.94x | 7.87% | 67.95% | 14.90% | $234.54 |
ABBVABBVIE INC. | 6.04x | 8.57% | 71.62% | -2.88% | $208.99 |
MRKMerck & Co., Inc. | 4.41x | 1.31% | 78.55% | 21.23% | $115.46 |
AZNAstraZeneca PLC | 5.28x | 8.63% | 81.31% | 21.88% | $200.47 |
NVSNovartis AG | 4.98x | 8.91% | 75.82% | 15.26% | $149.73 |
NVONovo-Nordisk A/S | 3.62x | 6.43% | 80.98% | 20.66% | $40.93 |
PFEPfizer Inc. | 2.47x | -1.64% | 75.81% | -3.51% | $27.22 |
BMYBristol-Myers Squibb Co. | 2.47x | -0.22% | 72.63% | — | $58.96 |
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 2.61x | 4.11% | 72.67% | -0.54% | $57.13 |
About
Abbott is a diversified healthcare company with leading products in cardiovascular devices, diabetes care, diagnostics, and nutrition. The company manufactures pacemakers, defibrillators, continuous glucose monitors, diagnostic testing equipment, and infant nutritional products. Approximately 60% of sales come from international markets, providing significant geographic diversification.